Of note, our ROR1 IHC prevalence results are lower than the results presented by another study performed via FC where ROR1 tumour membrane median positivity for MCL was 56%; DLBCL 50%; FL 28%; and AML 36% [5]. The gene discussed is ROR1; the disease is diffuse large B-cell lymphoma.